TearSolutions' Convertible Note - II Round

TearSolutions raised a round of funding on February 24, 2017. Investors include LaunchCapital.

TearSolutions is a drug development company focusing on 'dry eye', the most common eye disease. TearSolutions aims to advance a novel tear generation therapy for dry eye through phase II human clinica…

Articles about TearSolutions' Convertible Note - II Round: